Wednesday, 08 April 2020

India News

  • Panacea gets govt order worth $34 million

    India |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

    New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order worth $34 million (Rs 187.61 crore) for the supply of 345 million dos...Read more

  • Indian FIPB clears pharma FDI proposals worth $536 mn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    New Delhi: The Indian Foreign Investment Promotion Board (FIPB), which is the foreign investment approval authority, has cleared eight of the ten pending proposals of foreign drug firms tha...Read more

  • WHO: Invest in local research to improve healthcare

    India |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

    Singapore: WHO has urged countries to invest in local research in order to develop a system of universal health coverage tailored to each individual country's situation to help ensure that ...Read more

  • Arvind sets up $42.37 mn plant top tap US market

    India |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company has invested $42.37 million to set up a new manufacturing facility at ...Read more

  • BioEnable launch biometric kiosks

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Bangalore: BioEnable Technologies announced the launch of their new generation Biometric Kiosks. The device type is used for a number of different applications including food coupons, self...Read more

  • What are India's most eminent life science individuals saying about CSIR?

    India |  Analysis | By Rahul Koul Koul | 0 Comment | 21 Nov, 2012

    India's Council of Scientific and Industrial Research (CSIR), which was established in 1942 as an autonomous society and with 37 state-of-the-art institutes by Dr Shanti Swarup Bhatnagar, h...Read more

  • Ranbaxy, Gilead sign licensing agreement

    India |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    New Delhi: Ranbaxy Laboratories has entered into an in-licensing agreement with Gilead Sciences to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtrici...Read more

  • NSF brings Secondary Reference Standards to India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: NSF International, an independent global public health and safety organization which develops standards, and tests and certifies products for the pharmaceutical, dietary suppleme...Read more

  • Abuse of clinical trial laws need to be prevented

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 15 Oct, 2012

    Clinical trial is a process which involves testing of efficacy of drugs for the purpose of determination of safety, proper dosage range and side effects, prior to the drug being certified a...Read more

  • QIAGEN gets SFDA's nod for careHPV Test

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: QIAGEN announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform. The careHPV Test is the first molecular diagn...Read more

  • GlobalData: Osteoporosis market to be $8 bn

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the UK, Japan, China, and India will reach a value of $8 billion in 2022 ...Read more

  • Cipla gets drug pricing breather from Delhi Court

    India |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not to take coercive steps against pharma major Cipla. The company was tol...Read more

  • Industry body expresses concern over Nexavar decision

    India |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2012

    The Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the $4 billion biotechnology industry in India, reacted sharply to India's grant of a compulsory li...Read more

  • APAC ovarian cancer drug market to grow modestly'

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more

  • Hyderabad to host BioAsia from Jan 28

    India |  News | By BioSpectrum Bureau  | 0 Comment | 09 Nov, 2012

    Bangalore: The 10th edition of much anticipated annual biotechnology and life sciences platform BioAsia will be held in Hyderabad, India, from January 28 to 30, 2013. The event will be held...Read more

  • Indian Government strengthens clinical trials regulations

    India |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Bangalore: In a bid to strengthen the regulation and monitoring of clinical trials in the country, the Indian Government has announced several measures to strengthen the regulation and moni...Read more

  • BMS pledges $15 million to help curb diabetes in India and China

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: The Bristol-Myers Squibb Foundation has expanded its Together on Diabetes initiative to China and India, pledging $15 million over five years to help these developing nations wit...Read more

  • Dishman Pharma records 13.2% growth

    India |  Company results | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Bangalore: Dishman Pharma has posted a 13.24 percent growth in the fourth quarter of FY12 and reported a consolidated net profit of Rs 312.94 million for the quarter ended 31 March, 2012, u...Read more